The Fore River Bridge on the South Shore was closed to vehicular travel due to a mechanical issue.
PHILADELPHIA, September 12, 2025--(BUSINESS WIRE)--FORE Biotherapeutics, a registration stage biotherapeutics company dedicated to developing targeted therapies to treat patients with cancer, today ...
FORE Biotherapeutics Raises $67.4M to advance plixorafenib and support late-stage BRAF cancer therapy development worldwide.
PHILADELPHIA--(BUSINESS WIRE)--Fore Biotherapeutics (Fore Bio), a precision oncology company dedicated to developing innovative treatments that provide a better outcome for cancer patients, today ...
FORE Biotherapeutics, a registration stage company dedicated to developing targeted therapies to treat patients with cancer, today announced the closing of an upsized Series D-2 extension financing of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results